| (Values in U.S. Thousands) | Jun, 2022 | Jun, 2021 | Jun, 2020 | Apr, 2026 | Apr, 2026 |
| Sales | 440 | 1,980 | 190 | 0 | 0 |
| Sales Growth | -77.78% | +942.11% | unch | unch | unch |
| Net Income | -8,310 | -7,080 | -3,220 | 0 | 0 |
| Net Income Growth | -17.37% | -119.88% | unch | unch | unch |
Gbs Inc (GBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
GBS Inc. is a life sciences company. It engages in developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. GBS Inc. is based in NEW YORK.